세계의 다가불포화지방산 시장

Global Eicosapentaenoic Acid Market to Reach US$6.5 Billion by 2030

The global market for Eicosapentaenoic Acid estimated at US$3.5 Billion in the year 2024, is expected to reach US$6.5 Billion by 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Dietary Supplements & Functional Foods Application, one of the segments analyzed in the report, is expected to record a 11.7% CAGR and reach US$4.9 Billion by the end of the analysis period. Growth in the Pet & Animal Feeds Application segment is estimated at 7.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$895.0 Million While China is Forecast to Grow at 14.4% CAGR

The Eicosapentaenoic Acid market in the U.S. is estimated at US$895.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 14.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.1% and 8.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.

Global Eicosapentaenoic Acid (EPA) Market – Key Trends & Drivers Summarized

What Is Eicosapentaenoic Acid (EPA), And Why Is It Important in Nutrition and Health?

Eicosapentaenoic acid (EPA) is an omega-3 fatty acid primarily found in fatty fish and certain algae. As a polyunsaturated fatty acid, EPA plays a critical role in human health, particularly in supporting cardiovascular function, reducing inflammation, and promoting brain health. EPA is commonly recognized for its anti-inflammatory properties, making it an important nutrient in the management of various health conditions, including cardiovascular diseases, arthritis, and mental health disorders. Additionally, EPA is known to contribute to the synthesis of bioactive compounds called eicosanoids, which help regulate various physiological processes in the body.

The importance of EPA in nutrition is highlighted by its numerous health benefits. Regular consumption of EPA has been linked to improved heart health by lowering triglyceride levels, reducing the risk of arrhythmias, and decreasing blood pressure. Moreover, EPA plays a significant role in mental health, with studies suggesting that adequate levels of this fatty acid may help alleviate symptoms of depression and anxiety. As consumers become more health-conscious, the demand for EPA-rich foods and supplements is on the rise, driving the growth of the EPA market.

What Are the Main Applications of EPA, And How Do They Cater to Nutritional Needs?

Eicosapentaenoic acid (EPA) has several key applications, primarily in dietary supplements, functional foods, pharmaceuticals, and animal nutrition. In the dietary supplement sector, EPA is commonly available in the form of fish oil capsules, krill oil, and algal oil supplements. These products cater to consumers seeking to enhance their omega-3 intake for various health benefits, such as supporting cardiovascular health and reducing inflammation. The popularity of EPA supplements has surged, particularly among health-conscious individuals and those with specific health concerns, leading to a growing market for these products.

In the functional foods segment, EPA is increasingly being incorporated into a variety of food products, including dairy items, beverages, and snack bars. Manufacturers are recognizing the potential market for health-enhancing products that provide added nutritional value. By fortifying everyday foods with EPA, brands can cater to consumers looking for convenient ways to incorporate beneficial omega-3 fatty acids into their diets. This trend is especially relevant as the demand for healthy, functional foods continues to grow among consumers seeking to improve their overall well-being.

EPA is also gaining attention in the pharmaceutical industry, where it is being explored for its therapeutic applications. Research is ongoing to evaluate the efficacy of EPA in managing various medical conditions, including cardiovascular disease, inflammatory disorders, and mental health issues. As new clinical studies emerge, they contribute to the growing body of evidence supporting the health benefits of EPA, potentially leading to new pharmaceutical formulations that incorporate this important fatty acid.

Additionally, the animal nutrition sector is increasingly utilizing EPA in pet foods and aquaculture. In pet nutrition, EPA is being included in dog and cat food formulations to support joint health, skin condition, and overall well-being. The growing trend of premium pet foods, which emphasize health benefits and high-quality ingredients, is driving demand for products fortified with omega-3 fatty acids like EPA. In aquaculture, EPA is crucial for the growth and health of farmed fish, as it enhances feed quality and improves fish health and growth rates. The rising global demand for sustainably farmed seafood is further promoting the use of EPA in aquaculture feeds.

How Are Technological Advancements Impacting the EPA Market?

Technological advancements are significantly influencing the EPA market by improving production methods, extraction processes, and product formulations. One notable development is the innovation in extraction technologies that enhance the yield and quality of EPA from natural sources. Advanced methods, such as supercritical fluid extraction and cold pressing, enable manufacturers to obtain high-purity EPA oils while preserving their beneficial properties. These extraction techniques not only improve the efficiency of EPA production but also reduce the environmental impact associated with traditional extraction methods.

Moreover, the rise of algae-based sources of EPA is transforming the market landscape. As consumers become more aware of sustainability and ethical sourcing, algae-derived EPA products are gaining traction as a viable alternative to fish-based sources. Algal oil, which is rich in both EPA and docosahexaenoic acid (DHA), provides a plant-based option that appeals to vegetarians, vegans, and environmentally conscious consumers. The development of efficient algal cultivation and extraction technologies is supporting the growth of this segment, expanding the availability of EPA-rich products in the market.

Advancements in product formulation are also enhancing the efficacy and bioavailability of EPA supplements. Innovations in emulsification and encapsulation technologies allow for the creation of more stable and bioavailable EPA products that are easier for the body to absorb. These formulations can improve the overall effectiveness of EPA supplements and enhance consumer satisfaction. Additionally, the combination of EPA with other beneficial ingredients, such as DHA, antioxidants, and vitamins, is becoming increasingly common in supplement formulations, catering to consumer preferences for comprehensive health solutions.

Furthermore, digital technology and data analytics are playing a role in improving consumer engagement and product development within the EPA market. Companies are utilizing consumer feedback and market research data to better understand consumer preferences and tailor their product offerings accordingly. This data-driven approach helps manufacturers create targeted marketing strategies and develop innovative EPA products that meet the evolving needs of consumers.

Finally, ongoing research into the health benefits of EPA is leading to new applications and potential therapeutic uses. As scientific studies continue to explore the role of EPA in managing various health conditions, the market is likely to see an expansion of its applications. Increased awareness of the importance of omega-3 fatty acids, along with growing evidence supporting their health benefits, will likely drive demand for EPA-rich products in both consumer and clinical settings.

What Is Driving the Growth in the EPA Market?

The growth in the EPA market is driven by several key factors, including increasing consumer awareness of the health benefits of omega-3 fatty acids, rising demand for dietary supplements, and the expansion of the functional foods sector. One of the primary drivers is the growing recognition of EPA's role in supporting cardiovascular health, reducing inflammation, and promoting brain function. As consumers become more health-conscious and proactive about their well-being, the demand for EPA supplements and fortified products is on the rise.

The increasing prevalence of lifestyle-related health conditions, such as obesity, heart disease, and mental health disorders, is further fueling the demand for EPA. Consumers are seeking preventive health measures, and omega-3 supplementation, particularly with EPA, is increasingly viewed as a beneficial approach to supporting overall health. This trend is particularly prominent among aging populations who are looking for solutions to maintain cognitive function and manage chronic health issues.

The expansion of the functional foods market is another significant factor contributing to the growth of the EPA market. Consumers are increasingly interested in foods that provide additional health benefits, leading to a rise in demand for EPA-fortified products. Manufacturers are responding to this demand by incorporating EPA into a variety of food items, including dairy products, snacks, and beverages. The ability to offer health-enhancing options that fit into consumers' busy lifestyles is driving the growth of this segment.

Additionally, the trend toward sustainable and plant-based diets is promoting interest in algae-derived EPA products. As more consumers adopt vegetarian and vegan lifestyles, the demand for alternative sources of omega-3 fatty acids is rising. Algal oil, rich in both EPA and DHA, presents a sustainable and ethical option for those seeking to increase their omega-3 intake without relying on fish sources. This shift in consumer preferences toward plant-based solutions is likely to continue influencing the EPA market positively.

Finally, ongoing research and clinical studies investigating the therapeutic applications of EPA are driving market growth. As new evidence emerges regarding the potential benefits of EPA in managing specific health conditions, healthcare providers are increasingly recommending omega-3 supplementation. This growing body of research supports the use of EPA in clinical settings, contributing to the broader acceptance and utilization of this essential fatty acid.

In conclusion, the EPA market is experiencing robust growth driven by increasing consumer awareness of its health benefits, rising demand for dietary supplements and functional foods, and the trend toward sustainable and plant-based nutrition. Technological advancements in production and formulation, coupled with ongoing research into the therapeutic potential of EPA, will further enhance the market's prospects. As consumers prioritize their health and well-being, the demand for EPA-rich products is expected to flourish, shaping the future of nutrition and wellness.

SCOPE OF STUDY:

The report analyzes the Eicosapentaenoic Acid market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• BASF Nutrition
• Croda
• DSM
• EPAX
• GC Rieber Oils
• KD Pharma
• Orkla Health
• Polaris
• Shandong Yuwang Pharmaceutical
• Sinomega

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Eicosapentaenoic Acid - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Omega-3 Fatty Acids in Dietary Supplements Drives Growth of Eicosapentaenoic Acid (EPA) Market
  • Increased Adoption of EPA in Cardiovascular Health Products Expands Addressable Market
  • Surge in Demand for EPA in Functional Foods and Beverages Fuels Market Growth
  • Technological Advancements in EPA Extraction from Fish and Algae Propel Market Expansion
  • Growing Focus on EPA for Anti-Inflammatory and Joint Health Benefits Strengthens Business Case
  • Rising Use of EPA in Cognitive and Brain Health Supplements Sets the Stage for Market Growth
  • Surge in Adoption of EPA in Sports Nutrition and Fitness Products Expands Market Opportunities
  • Growing Demand for EPA in Infant and Maternal Nutrition Expands Addressable Market
  • Rising Focus on EPA for Eye Health and Vision Support Fuels Market Demand
  • Technological Advancements in Microencapsulation of EPA for Enhanced Stability Propel Market Growth
  • Surge in Demand for EPA in Elderly Care and Cognitive Decline Prevention Expands Market Growth
  • Rising Use of EPA in Animal Nutrition Expands Market Opportunities
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Eicosapentaenoic Acid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 3: World 15-Year Perspective for Eicosapentaenoic Acid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Dietary Supplements & Functional Foods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Dietary Supplements & Functional Foods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 6: World 15-Year Perspective for Dietary Supplements & Functional Foods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Infant Formula by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Infant Formula by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 9: World 15-Year Perspective for Infant Formula by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 12: World 15-Year Perspective for Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 15: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 16: World Eicosapentaenoic Acid Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Pet & Animal Feeds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Pet & Animal Feeds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Pet & Animal Feeds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 20: USA Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 21: USA Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: USA 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 23: Canada Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 24: Canada Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: Canada 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
• JAPAN
  • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 26: Japan Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 27: Japan Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: Japan 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
• CHINA
  • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 29: China Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 30: China Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: China 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
• EUROPE
  • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 32: Europe Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: Europe Historic Review for Eicosapentaenoic Acid by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: Europe 15-Year Perspective for Eicosapentaenoic Acid by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 35: Europe Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: Europe Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: Europe 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
• FRANCE
  • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 38: France Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: France Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: France 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
• GERMANY
  • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 41: Germany Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Germany Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: Germany 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 44: Italy Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Italy Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: Italy 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 47: UK Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: UK Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: UK 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 50: Spain Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Spain Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Spain 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 53: Russia Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Russia Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Russia 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Rest of Europe Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Rest of Europe 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 60: Asia-Pacific Historic Review for Eicosapentaenoic Acid by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Asia-Pacific 15-Year Perspective for Eicosapentaenoic Acid by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Asia-Pacific Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Asia-Pacific 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 65: Australia Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Australia Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Australia 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
• INDIA
  • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 68: India Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: India Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: India 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 71: South Korea Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: South Korea Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: South Korea 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 74: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Rest of Asia-Pacific Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Rest of Asia-Pacific 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 77: Latin America Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 78: Latin America Historic Review for Eicosapentaenoic Acid by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Latin America 15-Year Perspective for Eicosapentaenoic Acid by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 80: Latin America Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Latin America Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Latin America 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 83: Argentina Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Argentina Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Argentina 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 86: Brazil Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Brazil Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Brazil 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 89: Mexico Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Mexico Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Mexico 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 92: Rest of Latin America Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Rest of Latin America Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Rest of Latin America 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 95: Middle East Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 96: Middle East Historic Review for Eicosapentaenoic Acid by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Middle East 15-Year Perspective for Eicosapentaenoic Acid by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 98: Middle East Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Middle East Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Middle East 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 101: Iran Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Iran Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Iran 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 104: Israel Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Israel Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Israel 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 107: Saudi Arabia Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Saudi Arabia Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Saudi Arabia 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 110: UAE Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UAE Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: UAE 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 113: Rest of Middle East Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Rest of Middle East Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Rest of Middle East 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
• AFRICA
  • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 116: Africa Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Africa Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Africa 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION